Rational design of a novel peripherally-restricted, orally active CB1 cannabinoid antagonist containing a 2,3-diarylpyrrole motif
摘要:
A new series of 2,3-diarylpyrroles have been prepared and evaluated as CB1 antagonists. Modulation of the topological polar surface area allowed the identification of high affinity peripherally-restricted CB1 antagonists. Compound 11, obtained after further optimization of the metabolic profile displayed very low brain penetration, yet was able to reverse CP55940-induced gastrointestinal transit inhibition following oral administration. (C) 2010 Elsevier Ltd. All rights reserved.
PYRROLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
申请人:Barth Francis
公开号:US20070149596A1
公开(公告)日:2007-06-28
The invention concerns compounds of formula (I):
Wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
and R
9
are as defined herein. The invention also concerns the method for preparing said compounds and their therapeutic use.